This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Five Prime Therapeutics, Inc., Glaxosmithkline Intellectual Property Development Limited. Active years: 2020.
Company Filing History:
1 out of 77 
1 out of 242 
Years Active: 2020
Title: Amy W Hsu: Innovator in Muscle Treatment Technologies
Introduction
Amy W Hsu is a prominent inventor based in Moraga, California. She has made significant contributions to the field of medical technology, particularly in the treatment of muscle-related disorders. Her innovative approach has led to the development of a unique patent that addresses critical health issues.
Latest Patents
Amy W Hsu holds a patent for a groundbreaking treatment aimed at pathological muscle loss and weakness. The patent, titled "Methods of treating muscle wasting and other disorders with NOPE extracellular domain (ECD) polypeptides and NOPE ECD fusion molecules," provides novel methods for combating muscle wasting. This invention is crucial for individuals suffering from various muscle disorders.
Career Highlights
Throughout her career, Amy has worked with notable companies in the pharmaceutical and biotechnology sectors. She has been associated with GlaxoSmithKline Intellectual Property Development Limited and Five Prime Therapeutics, Inc. Her experience in these organizations has enriched her expertise and contributed to her innovative work.
Collaborations
Amy has collaborated with several professionals in her field, including Warren James Rocque and Aaron Curtis Hinken. These partnerships have fostered a collaborative environment that enhances the development of her inventions.
Conclusion
Amy W Hsu is a trailblazer in the field of muscle treatment technologies. Her patent for the NOPE treatment exemplifies her commitment to improving health outcomes for individuals with muscle disorders. Her work continues to inspire innovation in the medical field.